<DOC>
	<DOC>NCT01072513</DOC>
	<brief_summary>The purpose of this study is to evaluate semen for changes following treatment with proton radiation therapy.</brief_summary>
	<brief_title>Semen Analysis After Proton Therapy for Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Diagnosis of low to intermediate risk prostate cancer and elected to have proton radiation therapy at University of Florida Proton Therapy Institute (UFPTI). Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo. History of vasectomy. Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin. Current use of Avodart or Proscar.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Semen Analysis, Prostate Cancer, Proton Radiation</keyword>
</DOC>